Clinical Trial: ECOG-ACRIN EA8171

ECOG-ACRIN EA8171

Status: Open

NCT#03697148

Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

Tobacco Use Assessment Sub-Study (EAQ16T), Closed to Accrual, effective October 8, 2021.

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved